ATE340561T1 - Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen - Google Patents

Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen

Info

Publication number
ATE340561T1
ATE340561T1 AT04025138T AT04025138T ATE340561T1 AT E340561 T1 ATE340561 T1 AT E340561T1 AT 04025138 T AT04025138 T AT 04025138T AT 04025138 T AT04025138 T AT 04025138T AT E340561 T1 ATE340561 T1 AT E340561T1
Authority
AT
Austria
Prior art keywords
treatment
antiseptics
prophylaxis
production
human body
Prior art date
Application number
AT04025138T
Other languages
English (en)
Inventor
Wolfgang Fleischer
Karen Reimer
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE340561T1 publication Critical patent/ATE340561T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04025138T 1999-05-27 2000-05-25 Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen ATE340561T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19924313 1999-05-27

Publications (1)

Publication Number Publication Date
ATE340561T1 true ATE340561T1 (de) 2006-10-15

Family

ID=7909362

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00936804T ATE289805T1 (de) 1999-05-27 2000-05-25 Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
AT04025138T ATE340561T1 (de) 1999-05-27 2000-05-25 Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00936804T ATE289805T1 (de) 1999-05-27 2000-05-25 Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren

Country Status (20)

Country Link
US (1) US7468194B1 (de)
EP (2) EP1180018B1 (de)
JP (1) JP5616565B2 (de)
KR (1) KR100687781B1 (de)
CN (1) CN1197552C (de)
AT (2) ATE289805T1 (de)
AU (1) AU772314B2 (de)
BR (1) BR0010983A (de)
CA (1) CA2368192A1 (de)
CY (1) CY1105849T1 (de)
DE (3) DE60031016T2 (de)
DK (1) DK1502586T3 (de)
ES (2) ES2235891T3 (de)
HK (1) HK1046242B (de)
HU (1) HU229598B1 (de)
IL (2) IL146133A0 (de)
MX (1) MXPA01012170A (de)
PT (1) PT1502586E (de)
RU (1) RU2264827C2 (de)
WO (1) WO2000072823A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226729B1 (en) * 1998-05-27 2009-08-28 Euro Celtique Sa Preparation for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
EP1479379B1 (de) 2003-05-19 2007-08-29 Euro-Celtique S.A. Trockene liposomale PVP-Jod Zubereitungen
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
US8906966B2 (en) 2006-07-13 2014-12-09 Paul Sherwood Medicaments containing panthenol
EP2178526A1 (de) * 2007-07-13 2010-04-28 Prototype Bioforum Limited Panthenol enthaltende injizierbare pharmazeutische zusammensetzungen
CN101987109B (zh) * 2009-08-05 2012-07-04 天津金耀集团有限公司 含有聚维酮碘与环糊精包合糖皮质激素的眼用组合物
CN102429862B (zh) 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
CN103143053A (zh) * 2013-03-24 2013-06-12 山东康力医疗器械科技有限公司 新型聚维酮碘抗菌水胶体敷料及其制备方法
CN104147610A (zh) * 2014-06-26 2014-11-19 中国人民解放军第三○九医院 一种附载抗菌成分的高分子微纳米粒及其制备方法
CN106307543B (zh) * 2016-08-22 2020-02-07 青岛农业大学 一种麝香草酚纳米脂质体及其制备方法
CN109180600A (zh) * 2018-09-21 2019-01-11 五邑大学 一种麝香草酚类似物及其应用
CN111329824A (zh) * 2020-04-02 2020-06-26 东元科技有限公司 一种杀菌能力强的洗手消毒剂
US11590056B2 (en) * 2020-07-30 2023-02-28 Sartorius Stedim North America Freeze/thaw containment system for flexible pouch filled with biopharmaceutical fluid, and method of assembling a freeze/thaw containment system, using a protecting body

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (de) 1952-04-15 1900-01-01
US4113857A (en) 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (fr) 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
US4523589A (en) * 1983-06-29 1985-06-18 Krauser Robert S Method and apparatus for treating ailments
FR2591105B1 (fr) 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
SE8603812D0 (sv) 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
JPH0761940B2 (ja) 1986-11-17 1995-07-05 株式会社資生堂 外皮用リポソ−ム製剤
CH672733A5 (de) 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US4938965A (en) 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
CA1303503C (en) 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
DE3826946C1 (de) 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
JPH02204413A (ja) 1989-02-02 1990-08-14 Nonogawa Shoji:Kk 抗真菌外用製剤
WO1990011781A1 (en) 1989-04-04 1990-10-18 Alcon Laboratories, Inc. The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
US5232692A (en) 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
ES2060040T5 (es) 1989-05-31 1999-09-16 Fisons Plc Dispositivo y formulacion de inhalacion de medicamento.
RU2123338C1 (ru) * 1990-06-15 1998-12-20 Сайтел Корпорейшн Фармацевтическая композиция на основе медиатора межклеточной адгезии (варианты), способ ингибирования межклеточной адгезии, способ лечения воспалительного заболевания, способ анализа тестируемого соединения на способность ингибировать клеточную адгезию, способ получения соединения
US5128139A (en) 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (de) 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
EP0580860B2 (de) 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Verfahren zur herstellung einer festen dispersion
CA2109528A1 (en) 1991-05-01 1992-11-02 Gregory A. Prince A method for treating infectious respiratory diseases
ATE158951T1 (de) 1992-05-29 1997-10-15 Ggu Gesundheits Umweltforsch Vorrichtung zur erzeugung inhalierbarer wirkstoffpartikel
CA2097163C (en) * 1992-06-01 2002-07-30 Marianna Foldvari Topical patch for liposomal drug delivery system
WO1994014490A1 (de) 1992-12-23 1994-07-07 Bernhard Hugemann Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
US5552158A (en) 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (de) 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
US5270307A (en) 1993-03-26 1993-12-14 The Dow Chemical Company Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
WO1996014083A1 (de) 1994-11-04 1996-05-17 Polymun Scientific Immunbiologische Forschung Gmbh Applikation von sod in liposomen
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
AU7454698A (en) 1997-06-06 1998-12-21 Shionogi & Co., Ltd. Improvement in medicament administration system
HU226729B1 (en) 1998-05-27 2009-08-28 Euro Celtique Sa Preparation for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract

Also Published As

Publication number Publication date
IL146133A (en) 2006-12-31
HU229598B1 (en) 2014-02-28
RU2001135842A (ru) 2003-08-20
AU5216600A (en) 2000-12-18
ATE289805T1 (de) 2005-03-15
IL146133A0 (en) 2002-07-25
CY1105849T1 (el) 2011-02-02
HK1046242A1 (en) 2003-01-03
HUP0201038A3 (en) 2003-04-28
BR0010983A (pt) 2002-03-05
AU772314B2 (en) 2004-04-22
MXPA01012170A (es) 2002-06-21
EP1502586B1 (de) 2006-09-27
DK1502586T3 (da) 2007-02-05
PT1502586E (pt) 2007-01-31
WO2000072823A8 (en) 2001-06-07
HUP0201038A2 (en) 2002-09-28
HK1073252A1 (en) 2005-09-30
CN1197552C (zh) 2005-04-20
KR20020012234A (ko) 2002-02-15
EP1180018B1 (de) 2005-03-02
JP2003500436A (ja) 2003-01-07
EP1502586A1 (de) 2005-02-02
DE60031016T2 (de) 2007-05-16
ES2235891T3 (es) 2005-07-16
RU2264827C2 (ru) 2005-11-27
DE60031016D1 (de) 2006-11-09
CA2368192A1 (en) 2000-12-07
ES2274372T3 (es) 2007-05-16
DE20022718U1 (de) 2002-04-04
EP1180018A1 (de) 2002-02-20
HK1046242B (zh) 2005-08-12
US7468194B1 (en) 2008-12-23
JP5616565B2 (ja) 2014-10-29
CN1352551A (zh) 2002-06-05
WO2000072823A1 (en) 2000-12-07
DE60018409T2 (de) 2005-12-29
DE60018409D1 (de) 2005-04-07
KR100687781B1 (ko) 2007-02-28

Similar Documents

Publication Publication Date Title
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
DE69309701D1 (de) Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ES2157005T3 (es) Uso del acido boswellico y sus derivados para la inhibicion de la actividad normal y elevada de la elastasa de leucocitos o de la plasmina.
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
ATE245421T1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
UA36030A (uk) Препарат для лікування і профілактики респіраторних хвороб коней " сегп "
TW200701989A (en) Health care composition for oral cavity and manufacturing method thereof
RU93052444A (ru) Лекарственный препарат бан
TH58859A3 (th) สารผสมที่ทำให้เป็นกรดแล้วสำหรับการรักษาสภาพผิวหนังและเล็บเฉพาะที่

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1502586

Country of ref document: EP